WebApr 11, 2024 · There were 2,259 press releases posted in the last 24 hours and 407,835 in the last 365 days. WebDec 19, 2024 · CAMBRIDGE, Mass., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the …
Did you know?
WebSep 30, 2024 · Cerevel is conducting two adequately-powered placebo-controlled Phase 2 trials, known as EMPOWER-1 and EMPOWER-2. Data for both trials are expected in the first half of 2024. ... This press release contains forward-looking statements that are based on management’s beliefs and assumptions and on information currently available to … WebApr 11, 2024 · Cerevel Therapeutics announced it will report first quarter 2024 financial results and business updates on Wednesday, May 3, 2024, before the U.S. financial markets open. ... This press release contains forward-looking statements that are based on management’s beliefs and assumptions and on information currently available to …
WebJun 15, 2024 · CAMBRIDGE, Mass., June 15, 2024 (GLOBE NEWSWIRE) -- Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to CVL-871, a D1/D5 partial agonist in … WebMar 24, 2024 · Cerevel Therapeutics Announces Pricing of $300 Million Private Offering of Convertible Senior Notes and Concurrent $254 Million Public Offering of Common Stock. …
WebCAMBRIDGE, Mass., March 21, 2024 (GLOBE NEWSWIRE) -- Cerevel Therapeutics, (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain to treat … WebNov 10, 2024 · CAMBRIDGE, Mass., Nov. 10, 2024 (GLOBE NEWSWIRE) -- Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, today...
WebFeb 22, 2024 · CAMBRIDGE, Mass., Feb. 22, 2024 (GLOBE NEWSWIRE) — Cerevel Therapeutics, ( Nasdaq: CERE ), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, today reported financial results for the fourth quarter and full year ended December 31, 2024 and provided key pipeline and business updates. consumer reports online discount subscriptionWebJan 3, 2024 · Cerevel Therapeutics is dedicated to unraveling the mysteries of the brain to treat neuroscience diseases. The company is tackling diseases with a targeted approach to neuroscience that combines expertise in neurocircuitry with a focus on receptor selectivity. ... This press release contains forward-looking statements that are based on ... edwards technical supportWebJan 4, 2024 · CAMBRIDGE, Mass., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Cerevel Therapeutics, (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, today announced that chairperson and chief executive officer Tony Coles, M.D., will present at the upcoming 41stAnnual J.P. Morgan … consumer reports online gift subscriptionWebJun 30, 2024 · CAMBRIDGE, Mass., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Cerevel Therapeutics, (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, today reported financial results for the quarter ended June 30, 2024 and provided key pipeline and business updates. consumer reports online eyewearWebMar 21, 2024 · CAMBRIDGE, Mass., March 21, 2024 (GLOBE NEWSWIRE) -- Cerevel Therapeutics, CERE + Free Alerts consumer reports online eyeglassesWebDec 15, 2024 · CAMBRIDGE, Mass., Dec. 15, 2024 (GLOBE NEWSWIRE) -- Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, announced today the publication of data from its Phase 1b clinical trial of emraclidine, a novel muscarinic M4 selective positive allosteric … consumer reports online humidifiersWebApr 11, 2024 · CAMBRIDGE, Mass., April 11, 2024 (GLOBE NEWSWIRE) -- Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, today announced it will report first quarter 2024 financial results and business updates on Wednesday, May 3, 2024, before the U.S. … edwards tax service valdosta